Selektope (Sweden)
13 Mar 2018 11:19 (GMT+1)

I-Tech AB strengthens Selektope® supply chain with strategic acquisition

Selektope: Swedish bio-technology company I-Tech AB has today announced the strategic acquisition of manufacturing process technology and IP, for the production of medetomidine, from Cambrex Corporation (NYSE: CBM). The transaction consolidates the supply chain and improves I-Tech’s industrial capabilities. I-Tech AB has registered and patented medetomidine as a marine antifouling agent and is offering the active substance under the registered trademark Selektope® to the global marine co...
Login or Signup to read the full article

This post has been shared in your feed.

View Post
Its's free! Learn More
To read articles you will need to
signup or login.
It's totally free!
By signing up,you agree to our
terms of service and privacy policy